The LARA trial (NCT04699071), a multi-center, single-arm, phase 2 study, found that combining pembrolizumab (Keytruda) with ...
Clear cell odontogenic carcinoma (CCOC) is a rare malignant neoplasm of odontogenic origin that predominantly affects the jawbones, particularly the mandible. Typically presenting in middle-aged to ...
Select patients with oligometastatic ccRCC might be managed with a period of metastasis-directed therapy alone. Serial metastasis-directed radiation therapy may delay systemic therapy in clear cell ...
CAR T-cell therapy is being adapted for clear cell renal cell carcinoma, targeting CAIX and CD70 to improve efficacy and safety. Early trials like COBALT-RCC and TRAVERSE show promising disease ...
Myriad Genetics will present new data on its Precise MRD test for renal cell carcinoma at the AACR Annual Meeting. Myriad Genetics, Inc. announced that it will present new clinical data on its Precise ...
The AI model demonstrated an AUC of 0.71, which was significantly higher than the AUC of 0.54 reached using the tumor size-based model An artificial intelligence (AI)-based model for analyzing images ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results